Tuesday, 9 August 2022
  
Login

Australia's most trusted
source of pharma news

Tuesday, 09 August 2022
Listen to this story 
News

Top companies blasted for secrecy

Posted 4 August 2022 AM

Researchers are calling on the pharma industry to make clinical trial data underpinning cancer drug approvals available as soon as they are registered, after finding more than half of the data remains hidden.

The international team led by Flinders University in Adelaide looked at what proportion of clinical trials underpinning the registration of cancer medicines in the US over the past 10 years were eligible for sharing with qualified researchers.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Sales & Customer Relations (11)

Clinical & Medical, R&D (11)

Regulatory, Pharmacovigilance & QA (5)

Devices (1)

Other (15)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.